🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Visit myeloma.org/sparkcures to start searching today! Or get even more personalized options when you create an account on myeloma.org #ash24 #imfash24 SparkCures

Risk stratification for #SMM to hit that sweet spot: Treat or not Treat; not too early, not too late. 20-2-20+HRCA #IMWG #MMsm #myeloma

Shedding light and adding history to #Aquila trial for #SMM. #myeloma #MMsm

Muzaffar Qazilbash marivi mateos Verónica González 1q gain (not amp) is regularly associated with worse outcomes. However the impact is not strong enough for it to be called high risk (1q amp is). Statistically powerful due to its high prevalence. Same story as -13 by FISH.

💯 agree! Medicine is a “Team Sport”, a precision watch with interconnecting cogs. Pick the analogy, we all need to work together, respecting what we each bring to the patient experience.

Well deserved! 🏆 Patients are "hungry" for this information. Thank you for all you do. #MMSM #ASH24

Thank you Dr. Joe for leading this webinar and Drs. Munshi, Rajkumar and Faiman for capturing the excitement of #ASH24 and Sharing the H O P E! Joseph Mikhael Beth Faiman PhD Vincent Rajkumar Nikhil C. Munshi, MD

Excellent educational offering by @IMFMyeloma with #IMFASH24 updates by an expert panel. Topics from #SMM➡️#myeloma ➡️#mmMRD & patient-centric abstracts. See replay myeloma.org #MMsm @JMikhaelMD Vincent Rajkumar Beth Faiman PhD Nikhil C. Munshi, MD

Think about your options when it comes to that Holiday buffet! 😆

Is there anything better than a golden? Yes, 3 of them! 💜

Many thanks to Delta pilot Brandon on DL2953 flight MSP➡️MCO for jumping into the driver seat @ short notice. 🙏 colleagues dad is ok. #HappyHolidays. #teamwork

Anito-Cel Demonstrates Safety and Early Efficacy in R/R Multiple Myeloma onclive.com/view/anito-cel… via OncLive.com An amazing ORR of 100% with many deep responses!

In this short clip, myeloma nutrition expert Dr. Urvi A. Shah Urvi Shah explains the balance between the genes and the immune system, and how they affect #multiplemyeloma.

Between abbreviations, treatment names, and test results, it can be hard to stay up to date with the latest myeloma research. For easy-to-understand insights from #ASH24, join today’s webinar with Joseph Mikhael Jan 8 at 6 pm ET Register: buff.ly/4gGUzkS

I am looking forward to our webinar today. Let’s go Dr Joe!#IMFmyeloma

Join a dynamic education program for people living with #myeloma. I will be there. I hope you will join us! International Myeloma Foundation Robin Tuohy Joseph Mikhael Yelak Biru Sylviads #MMSM

Press Release: New Sarclisa subcutaneous formulation met co-primary endpoints in the IRAKLIA phase 3 study in #myeloma #MMsm ⁦Sanofi Myeloma sanofi.com/en/media-room/…

Philly folks, join us for a great #Myeloma learning event with great speakers. Registration is free. #MMSM Joseph Mikhael International Myeloma Foundation Robin Tuohy Sylviads

The #IMF is tailoring education to meet patients where they are at. #NDMM or #RRMM, Patient or Care Partner - there is a session for you at the Philly PFS. #Myeloma #MMSM International Myeloma Foundation Joseph Mikhael Sylviads Robin Tuohy

April is #MinorityCancerAwarenessMonth—a time to shed light on the disparities in myeloma. Black Americans are twice as likely to be diagnosed with myeloma yet often face delays in diagnosis and treatment. Knowledge is power. #IMFMPOWER mpower.myeloma.org